XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2,811 $ 266 $ 504,162   $ (648,511) $ (144,083)
Balance (in shares) at Dec. 31, 2020   265,582        
Changes in Stockholders' Equity (Deficit)            
Conversion of preferred stock   $ 54 45,512     45,566
Conversion of preferred stock (in shares)   54,166        
Issuance of common stock, net   $ 113 200,327     200,440
Issuance of common stock (in shares)   112,571        
Exercise of stock options and ESPP purchases   $ 4 3,885     3,889
Exercise of stock options and ESPP purchases (in shares)   5,027        
Exchange and conversion of convertible notes, net   $ 5 6,496     6,501
Exchange and conversion of convertible notes, net (in shares)   4,925        
Issuance of common stock for vested RSUs and ESPP purchase   $ 3 47     50
Issuance of common stock for vested RSUs and ESPP purchase (in shares)   2,854        
Stock-based compensation expense     4,833     4,833
Net Income (Loss)         (429,820) (429,820)
Other comprehensive loss, net of tax       $ (16)   (16)
Balance at Jun. 30, 2021   $ 445 765,262 (16) (1,078,331) (312,640)
Balance (in shares) at Jun. 30, 2021   445,125        
Increase (Decrease) in Temporary Equity            
Issuance of convertible preferred stock, net 42,756          
Conversion of preferred stock (45,567)          
Balance at Dec. 31, 2020 $ 2,811 $ 266 504,162   (648,511) (144,083)
Balance (in shares) at Dec. 31, 2020   265,582        
Changes in Stockholders' Equity (Deficit)            
Net Income (Loss)           (302,500)
Balance at Dec. 31, 2021   $ 447 765,215 (212) (950,985) (185,535)
Balance (in shares) at Dec. 31, 2021   447,282        
Balance at Mar. 31, 2021   $ 428 711,698   (898,025) (185,899)
Balance (in shares) at Mar. 31, 2021   427,915        
Changes in Stockholders' Equity (Deficit)            
Issuance of common stock, net   $ 13 48,340     48,353
Issuance of common stock (in shares)   12,831        
Exercise of stock options and warrants   $ 1 2,190     2,191
Exercise of stock options and warrants (in shares)   1,588        
Issuance of common stock for vested RSUs and ESPP purchase   $ 3       3
Issuance of common stock for vested RSUs and ESPP purchase (in shares)   2,791        
Stock-based compensation expense     3,034     3,034
Net Income (Loss)         (180,306) (180,306)
Other comprehensive loss, net of tax       (16)   (16)
Balance at Jun. 30, 2021   $ 445 765,262 (16) (1,078,331) (312,640)
Balance (in shares) at Jun. 30, 2021   445,125        
Balance at Dec. 31, 2021   $ 447 765,215 (212) (950,985) (185,535)
Balance (in shares) at Dec. 31, 2021   447,282        
Changes in Stockholders' Equity (Deficit)            
Issuance of common stock, net   $ 3 8,001     8,004
Issuance of common stock (in shares)   3,077        
Exercise of stock options and warrants   $ 9 230     239
Exercise of stock options and warrants (in shares)   9,211        
Issuance of common stock for vested RSUs and ESPP purchase   $ 7 56     63
Issuance of common stock for vested RSUs and ESPP purchase (in shares)   6,849        
Stock-based compensation expense     4,321     4,321
Shares withheld related to net share settlement of equity awards   $ (1) (1,183)     (1,184)
Shares withheld related to net share settlement of equity awards (in shares)   (1,093)        
Net Income (Loss)         190,949 190,949
Other comprehensive loss, net of tax       (916)   (916)
Balance at Jun. 30, 2022   $ 465 776,640 (1,128) (760,036) 15,941
Balance (in shares) at Jun. 30, 2022   465,326        
Balance at Mar. 31, 2022   $ 463 775,172 (837) (864,267) (89,469)
Balance (in shares) at Mar. 31, 2022   463,229        
Changes in Stockholders' Equity (Deficit)            
Exercise of stock options and warrants     68     68
Exercise of stock options and warrants (in shares)   127        
Issuance of common stock for vested RSUs and ESPP purchase   $ 3 (2)     1
Issuance of common stock for vested RSUs and ESPP purchase (in shares)   3,063        
Stock-based compensation expense     2,585     2,585
Shares withheld related to net share settlement of equity awards   $ (1) (1,183)     (1,184)
Shares withheld related to net share settlement of equity awards (in shares)   (1,093)        
Net Income (Loss)         104,231 104,231
Other comprehensive loss, net of tax       (291)   (291)
Balance at Jun. 30, 2022   $ 465 $ 776,640 $ (1,128) $ (760,036) $ 15,941
Balance (in shares) at Jun. 30, 2022   465,326